Ubs Group Ag Genocea Biosciences, Inc. Transaction History

Ubs Group Ag

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.96 - $1.35 $1,083 - $1,524	-1,129 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.95 - $1.99 $1,072 - $2,246	1,129 New	1,129 $1,000
Q3 2021 Nov 15, 2021	SELL	$1.74 - $2.33 $6,671 - $8,933	-3,834 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.06 - $2.82 $7,898 - $10,811	3,834 New	3,834 $9,000
Q4 2020 Feb 11, 2021	SELL	$1.91 - $2.67 $35,461 - $49,571	-18,566 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$1.81 - $5.53 $33,604 - $102,669	18,566 New	18,566 $43,000
Q2 2020 Jul 31, 2020	SELL	$1.66 - $3.06 $406 - $749	-245 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$1.26 - $2.73 $308 - $668	245 New	245 $0
Q4 2019 Feb 14, 2020	SELL	$2.05 - $2.82 $6,055 - $8,330	-2,954 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.9 - $4.07 $4,999 - $7,016	-1,724 Reduced 36.85%	2,954 $9,000
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.71 $16,232 - $31,389	4,678 New	4,678 $19,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.